Deutsche Bank
JANX icon

Deutsche Bank’s Janux Therapeutics JANX Stock Holding History

Deutsche Bank’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665K Buy
43,278
+6,658
+18% +$96.4K ﹤0.01% 2619
2026
Q1 		$509K Buy
36,620
+4,450
+14% +$61K ﹤0.01% 2566
2025
Q4 		$444K Sell
32,170
-3,988
-11% -$93.8K ﹤0.01% 2630
2025
Q3 		$884K Buy
36,158
+6,140
+20% +$150K ﹤0.01% 2245
2025
Q2 		$693K Sell
30,018
-69,673
-70% -$1.84M ﹤0.01% 2293
2025
Q1 		$2.69M Buy
99,691
+6,662
+7% +$251K ﹤0.01% 1563
2024
Q4 		$4.98M Buy
93,029
+73,912
+387% +$3.91M ﹤0.01% 1329
2024
Q3 		$868K Buy
19,117
+6,693
+54% +$291K ﹤0.01% 2183
2024
Q2 		$520K Buy
12,424
+5,699
+85% +$268K ﹤0.01% 2315
2024
Q1 		$253K Sell
6,725
-248
-4% -$5.4K ﹤0.01% 2708
2023
Q4 		$74.8K Hold
6,973
– – ﹤0.01% 3340
2023
Q3 		$70.3K Hold
6,973
– – ﹤0.01% 3316
2023
Q2 		$82.8K Sell
6,973
-3,485
-33% -$46.6K ﹤0.01% 3350
2023
Q1 		$127K Buy
10,458
+2,245
+27% +$37.4K ﹤0.01% 3217
2022
Q4 		$108K Buy
8,213
+114
+1% +$1.67K ﹤0.01% 3300
2022
Q3 		$110K Sell
8,099
-1,143
-12% -$15.3K ﹤0.01% 3269
2022
Q2 		$113K Sell
9,242
-1,356
-13% -$16.1K ﹤0.01% 3470
2022
Q1 		$152K Buy
10,598
+1,980
+23% +$32.4K ﹤0.01% 3410
2021
Q4 		$170K Buy
8,618
+433
+5% +$9.07K ﹤0.01% 3457
2021
Q3 		$178K Buy
+8,185
New +$235K ﹤0.01% 3626

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Deutsche Bank's JANX Position: Q2 2026 in Review

Deutsche Bank increased its Janux Therapeutics (JANX) stake by 18% in Q2 2026, buying an estimated $96.4K and bringing the position to 43,278 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #2619.

Deutsche Bank first reported a position in JANX in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.98M in Q4 2024. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Deutsche Bank held 43,278 shares of Janux Therapeutics worth $665K as of Q2 2026.
  • Deutsche Bank bought 6,658 Janux Therapeutics shares in Q2 2026, an estimated $96.4K.
  • Janux Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2619 holding.
  • Deutsche Bank first reported a position in Janux Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Deutsche Bank's Janux Therapeutics position peaked at $4.98M in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.